Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS
 

Two ELS Executives Contribute to Newly Released Industry Guidebook

Excel Life Sciences is proud to announce that two members of our management team are contributors to a newly released publication by Dr. S.K. Gupta, Head, Department of Clinical Research at Delhi Institute of Pharmaceutical Sciences & Research. The new book published by Jaypee Brothers and titled “Drug Discovery and Clinical Research”, is a comprehensive guide for clinical research professionals, students and others interested in learning about the background, key principles, functions and trends that drive new drug development. 

Specifically, Dr. Saurendra Das, Country Head and Director of Operations for Excel Life Sciences and Dan McDonald, VP Business Strategy contributed two chapters to the book, Chapter 6 “Medical Devices-Regulations and Research”(Das, p.222) and Chapter 14 “Principles of Patient Recruitment” (McDonald, p.373).  This is Dr. Gupta’s 2nd book on the topic, and Dr. Das’ 2nd time contributing. For more information and to order a copy, please click here
 
Latest News

The Hotbed Driving Force in Biotech: Massachusetts

Verastem, Inc. Bucks the Trend, Raises $55 Million in IPO

Why Biogen Idec, Inc. (Massachusetts) Got Out of the Corporate VC Business

Infinity Pharmaceuticals Inc. Halts Phase II Cancer Drug Trial

Gladstone Institute Scientists Identify Protein That Contributes to Symptoms of Parkinson's Disease

Theraclone Sciences, Inc. and VLST Corp. Creators Form

Pharma Giant Bayer AG Plans to Create 1,000 New Jobs in Australia

BioMarin Pharmaceutical Inc. Seeks to Buttress Rare-Disease Push With Deals

In Schizophrenia Research, a Path to the Brain Through the Nose, Study

Will You Have a Heart Attack or Stroke? Northwestern University Study

Rivals See No Need to Match Roche's Big Gene Bet

Mutations in 2 Genes Linked to Rare Autism-Related Disorder, University of California, San Diego (UCSD) Study

James Murdoch to Quit GlaxoSmithKline Board

Obese People Encounter More Pain? Reveals

Pfizer Inc. Sued by Employees Over Retirement Plans

Caffeine May Alter Women's Estrogen Levels, Study

Autism: Kids Prefer Solo, Not Social, Screen Time, Washington University Study

How Work Tells Muscles to Grow, Reveals

Bristol-Myers Squibb Company Delivers Solid Fourth Quarter Capping a Year Highlighted by New Product Approvals, Continued Execution of Strategic Transactions and Good Operating Performance

Factors Linked to Age of Onset of Menopause Identified, Boston University Study

Active Ingredient in Viagra Shrunk Disfiguring Growths in Kids, Stanford University School of Medicine Study

Watson Pharmaceuticals, Inc. Reaches Settlement With Mallinckrodt Inc. Over Exalgo(R)

Amgen to Buy Micromet for $1.16 Billion

Abbott Laboratories Cuts 700 Jobs, Even as Profits Rise

Celgene to Acquire Avila Therapeutics for Up to $925 Million

Ranbaxy Laboratories May Face Permanent Injunction in U.S

Roche's Avastin Fights Early Breast Cancer in 2 Studies: Will it be Re-approved?

Novartis AG to Pay $99 Million to Settle Federal Lawsuit over Sales Representatives' Overtime Pay

Illumina, Inc. Plans Poison Pill to Thwart Roche Bid

Protein in Brain Could Be a Key Target in Controlling Alzheimer???s, Temple University Study

Merck & Co., Inc. Gets Positive Opinion for Remicade in New Indication

Bill & Melinda Gates Foundation Donates $750 Million to Fight AIDS, TB and Malaria

Lonza Inc. Boots Out CEO as 2011 Profit Plunges

ChemoCentryx, Inc. Sets $14-$16 Range for IPO

Unity Management Group Subsidiary Announces First Contracts of 2012 With Purdue Pharma L.P. and Novartis AG

China Health Resource Signs Two New Agreements for the Sale of Gastrodia Valued at $10 Million

Pfizer Inc. Lipitor Plan Might Not Be "Worth It," Watson Pharmaceuticals, Inc. CEO Says

Working Too Much is Correlated With Two-Fold Increase in Likelihood of Depression, University College London Study

Chemists Synthesize Artificial Cell Membrane, University of California, San Diego (UCSD) Study

CEL-SCI to Raise $5.76 Million in Registered Direct Offering

Paula Deen Publicist Quits Over Novo Nordisk A/S Deal

Kansas Bioscience Authority Audit Slams Former CEO

FDA Approves LEO Pharma's Picato?? (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing

Drinking Black Tea May Cut Blood Pressure, Reveals

University of California, Berkeley (CAL) Study Shows How Stress Triggers Immune System

Mayo Clinic Study: Men at Higher Risk for Mild Memory Loss Than Women

FDA Chides Celgene, Novartis AG on Drug Promotion

Longer Bones Give Sprinters Speed, Pennsylvania State University Study

Prenatal Testosterone Linked to Increased Risk of Language Delay for Male Infants, University of Western Australia Study

High Animal Fat Diet Increases Gestational Diabetes Risk, National Institutes of Health (NIH) Study

Pycnogenol (French Maritime Pine Bark Extract) Shown to Improve Visible Signs of Aging in New Study, Study

BioPharm Executive: Embracing Generics and Emerging Markets

Roche Makes $5.7 Billion Hostile Bid for Diagnostic Company Illumina, Inc.

Johnson & Johnson 4Q Profit Slumps 89% On Charges

Jubilant Life Sciences Buys Out Eli Lilly and Company Stake in Joint Venture

Johnson & Johnson Won't Reopen Shuttered Plant Until 2013

Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims

Scientists Produce World's First Magnetic Soap, Study

Takeda Pharmaceutical Co. Ltd. Wins FDA Approval for New Way to Adminster Velcade to Patients

Jazz Pharmaceuticals, Inc. Announces New Executive Appointments

Gene Mutations May Boost Ovarian Cancer Survival, University of California, Los Angeles (UCLA) Study

Merck & Co., Inc.'s Cholesterol Drug Vytorin to Get New Label

Almirall and Galapagos NV Enter Research Alliance for Up to EUR $7.5 Million

UCB, Inc. Announces FDA Approval for Keppra?? in Infants and Children from One Month of Age with Partial Onset Seizures

High Levels of Fructose Consumption by Adolescents May Put Them at Cardiovascular Risk, Study

National Institute for Clinical Excellence (NICE) Backs Bristol-Myers Squibb Company, Pfizer Inc.'s

Lack of ZZZs May Fuel Appetite, Uppsala Universitet Study

Novartis AG Cautious on Outlook as Profit Drops 46%

ProSensa B.V. Raises Around $30 Million to Progress Exon-Skipping Antisense Oligonucleotides

Entry Point for Hepatitis C Infection Identified, University of Illinois Study

Brown Fat Burns Calories in Adult Humans, Study

Frying With Olive, Sunflower Oil OK for Heart, Study

Macoven Pharmaceuticals, LLC Named in Suit for Patent Violation and Lanham Act Violation

Expose to Common Chemicals Reduce Effectiveness of Vaccines in Kids, Harvard School of Public Health Study

Pfizer Inc. Starting to Sell Pain Drug With Acura Pharmaceuticals, Inc. Technology

Tall? That May Be Good News for Your Heart, Harvard Medical School Study

Magic Mushrooms May Help Treat Depression: How?, Imperial College London Study

Vertex Pharmaceuticals (MA) Vows to Fight on With Alios BioPharma Drugs in High-Stakes Hepatitis C Race

Watson Pharmaceuticals, Inc. Buys Strides Arcolab Limited' Australia Unit for $396 Million

Cleveland Biolabs Inc. Reorganizes Management, CEO to Step Down

GlaxoSmithKline's Dutasteride May Slow Low-Risk Prostate Cancer: Debate Heats Up

Curing Cancer Relies on Genome Mapping With DNA Evidence Guiding Treatment, National Cancer Institute Reveals

Sanofi (France)'s Genzyme Corporation Announces FDA Approval of Framingham Manufacturing Plant

Oncolytics Biotech Inc. Announces C$15 Million Bought Deal Financing

Overweight Linked to Acne in Teen Girls, Study

immatics biotechnologies GmbH Presents Positive Phase II Results With its Therapeutic Cancer Vaccine IMA910 in Patients With Advanced Colorectal Cancer at the 2012 American Society of Clinical Oncology Gastrointestinal Cancers Symposium

India: Merck KGaA to Focus on Women's Health Care, Cardiology, Diabetes

Roche Settles Claims Over Genentech's Raptiva Psoriasis Drug, Lawyer Says

28 Deaths in Pakistan Due to Suspected Drugs Reaction, Pharmaceutical Factory Sealed

University of Florida Researchers Develop Gene Therapy That Could Correct a Common Form of Blindness

POET Gets New Partner in $250 Million Cellulosic Ethanol Plant in Iowa

Biogen Idec, Inc. (Massachusetts), Elan Corporation PLC Win FDA Approval of Label Change for Tysabri

Molecular Fingerprint Discovered That May Improve Outcomes for Head and Neck Cancer Patients, Albert Einstein College of Medicine Study

Spectrum Pharmaceuticals, Inc. Touts Lymphoma Drug Study Results

Columbia Laboratories, Inc. Fails to Win FDA Panel Nod on Preterm Birth Gel; Stock Falls -0.8906(56.37%) @ 12:55PM EST

Gene Switch "Key to Heart Health," Gladstone Institute Study

Study Links Sleep Apnea and Sudden Deafness, Study

Keeping Brain Sharp May Ward Off Alzheimer's Protein, University of California, Berkeley (CAL) Study

Do Women Feel More Pain Than Men? Stanford University Study Says, "Yes,"

FDA Lifts Hold on Insmed Incorporated's Lung Disease Drug

Advanced Cell Technology: Stem Cell Retinal Implants Safe

Roche Workers in Poland Protest Hiring Practices

Smoking During Pregnancy Not Linked to Autism, Drexel University Study

BioMarin Pharmaceutical Inc.'s Dwarfism Medicine Marks Growth of $400,000 Rare-Disease Drugs

EntreMed, Inc. Raises $10 Million to Progress Clinical Anticancer Pipeline and Expand R&D

More Evidence for Oxaliplatin as Colon Cancer Chemotherapy, University of Virginia Study

LanzaTech Raises $58 Million in Series C Round; Petronas Becomes Strategic Investor

The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With APP Pharmaceuticals

Anthrax Vaccine Shows Promise in Monkeys, Study

Autism Redefined: Yale University Researchers Study Impact of Proposed Diagnostic Criteria

Alexza Pharmaceuticals, Inc. Announces Extension of the ADASUVE??? PDUFA Goal Date by Three Months

Trius Therapeutics Earns $5 Million Milestone Payment From Bayer HealthCare for Successful Completion of First Phase 3 Trial of Tedizolid

Alnylam Pharmaceuticals to Shed a Third of Its Work Force

Novartis AG's Gilenya Reviewed by EU After 11 Patient Deaths

New Genetic Clues to Breast Cancer? University of Cambridge Study

Plant Flavonoid Luteolin Blocks Cell Signaling Pathways in Colon Cancer Cells, Reveals

Nektar Therapeutics (CA)'s Drug Diversity May be Its Strength

Erasmus Medical College, University of Wisconsin Flu Researchers Pause to Weigh Risks After Creating More Lethal Strain

Exelixis, Inc. Reports Positive Preliminary Phase 2 Cabozantinib Data in Patients With Hepatocellular Carcinoma

Rapid Infant Growth Linked to Asthma in Study, Reveals

Gladstone Institute Scientists Identify Genetic Mechanism Linked to Congenital Heart Disease

Another Clue in the Mystery of Autism, Northwestern University Study

Exposure to Chemical Found in Personal Care Products May Contribute to Childhood Obesity, Mount Sinai School of Medicine Study

Pomegranate Seed Oil Doesn't Cool Hot Flashes, Medical University of Vienna Study

ProTrials Research, Inc. Establishes New Subsidiary in United Kingdom to Strengthen Business Operations in Europe

Upcoming Events

    Read more..
Related Links

    Read more..
Search
Search :